Skip to content

Released Mar 30, 2015, after the close

10-Q filed Mar 31, 2015, 274 days after period end · 0001193125-15-112307

Q2 2014 · 10-Q
Revenue$100.99M+3.4% vs Q2 2013+1.0% vs Q1 2014
Net Income-$683.00KN/M vs Q2 2013N/M vs Q1 2014
EPS Diluted-$0.04N/M vs Q2 2013N/M vs Q1 2014
Gross Profit$75,571,000−0.2%
Operating Income$6,704,000−3.1%
Operating Cash Flowderived$28,086,000+47.2%
Free Cash Flowderived$25,639,000+108.7%
Margins · derived
Gross margin74.8%−2.8 pt vs Q2 2013
Operating margin6.6%−0.4 pt vs Q2 2013
Net margin-0.7%+2.4 pt vs Q2 2013

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2014Q2 2013Q2 2012Q2 2011
Revenue$100.99M$97.64M$111.60M$108.22M
Net Income-$683.00K-$3.01M$8.80M$5.40M
EPS Diluted-$0.04-$0.16$0.46$0.29

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR